New drug trial aims to tame painful psoriatic arthritis
NCT ID NCT07486960
Summary
This study is testing whether an investigational drug called tulisokibart can help control psoriatic arthritis symptoms. About 140 adults with active psoriatic arthritis will receive either the drug or a placebo to compare effects. Researchers will measure improvements in joint pain, swelling, and physical function over 16 weeks while monitoring safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.